Results · Apr-Jun 2026 · filed 14 Aug 2026
Cholamandalam Financial Holdings Q1 FY27 results
Sales grew 20% to ₹11,114 crore from ₹9,296 crore in Apr-Jun 2025.
Operating profit grew 24% to ₹6,392 crore, an operating margin of 57.5% (up 2.1 points from a year ago).
Net profit grew 42% to ₹1,789 crore from ₹1,260 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +6%, net profit +10%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 11,114 | 9,296 | +20% |
| Operating profit (EBITDA) | 6,392 | 5,154 | +24% |
| Operating margin | 57.5% | 55.4% | +2.1 pts |
| Net profit | 1,789 | 1,260 | +42% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Chola MS reported Apr–Jun 2026 gross direct premium income of ₹1,860 crore, growing 2.6% amid industry headwinds in motor & health. Management is undertaking corrective measures in motor OD claims & health profitability while maintaining disciplined underwriting across all segments.
The last 7 quarters
Filings that week
- 20 Aug 2026Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- 18 Aug 2026Shareholder Meeting / Postal Ballot-Outcome of AGM
- 17 Aug 2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- 15 Aug 2026Shareholder Meeting / Postal Ballot-Outcome of AGM
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 14 Aug 2026Results - Financial Results - 30-06-2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.